| Drew M Smith, LCSW | |
|
1471 N 1200 W, Orem, UT 84057-2449 | |
| (801) 802-9464 | |
| (801) 802-7861 |
| Full Name | Drew M Smith |
|---|---|
| Gender | Male |
| Speciality | Social Worker - Clinical |
| Location | 1471 N 1200 W, Orem, Utah |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1639490683 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 1041C0700X | Social Worker - Clinical | 374975-3501 (Utah) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Drew M Smith, LCSW 1471 N 1200 W, Orem, UT 84057-2449 Ph: (801) 802-9464 | Drew M Smith, LCSW 1471 N 1200 W, Orem, UT 84057-2449 Ph: (801) 802-9464 |
News Archive
Ambit Biosciences Corporation and Astellas Pharma Inc. today announced that they have entered into a worldwide agreement to jointly develop and commercialize FLT3 kinase inhibitors in oncology and non-oncology indications.
People with diabetes - especially the 20 to 40 percent with diabetic kidney disease - are among the most at risk for serious complications and death from COVID-19.
Transposagen Biopharmaceuticals, Inc., based in Lexington, KY, has announced today that it has added 170 genetically modified rats and related biomaterials to its database of laboratory rats with a genetic modification that can mimic a human disease. These animals are used by academic, pharmaceutical, and biotech scientists for drug discovery and development research and will be sold under Transposagen's new TGEM(TM) Rat Models brand.
The European Society for Paediatric Gastroenterology, Hepatology and Nutrition has today issued new guidance to physicians on the diagnosis of celiac disease in children recommending the no-biopsy approach at diagnosis for the majority of children suspected of having the disease.
A large international Canadian-led clinical trial investigating a new way to prevent breast cancer in women at increased risk of developing the disease has found that the drug exemestane reduces this risk by 65 per cent compared with placebo.
› Verified 2 days ago
Katie Fishman, Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 600 S Geneva Rd, Orem, UT 84059 Phone: 801-877-5300 | |
Alicia Hills, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 202 E 800 S Ste 105, Orem, UT 84058 Phone: 385-283-1032 | |
Morgan Oliphant, Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 1255 N 1200 W, Orem, UT 84057 Phone: 801-229-1181 | |
Rebecca Jane Mcnairy, Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 1125 W Center St, Orem, UT 84057 Phone: 801-903-5903 | |
Erin Elizabeth Vasquez, LCSW, RPT Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 1255 N 1200 W, Orem, UT 84057 Phone: 801-229-1181 Fax: 801-229-2787 | |
Mr. Mark James Capell, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 313 E 1200 S, Suite 104, Orem, UT 84058 Phone: 801-377-1595 Fax: 801-377-1598 | |
Terry R Routt, LCSW Clinical Social Worker Medicare: Medicare Enrolled Practice Location: 570 E 1400 S, Orem, UT 84097 Phone: 801-426-6661 Fax: 801-426-6660 |